2018
Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium
Frazier AL, Stoneham S, Rodriguez-Galindo C, Dang H, Xia C, Olson TA, Murray MJ, Amatruda JF, Shaikh F, Pashankar F, Billmire D, Krailo M, Stark D, Brougham MFH, Nicholson JC, Hale JP. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium. European Journal Of Cancer 2018, 98: 30-37. PMID: 29859339, DOI: 10.1016/j.ejca.2018.03.004.Peer-Reviewed Original ResearchConceptsChildren's Oncology GroupEvent-free survivalOncology GroupClinical trialsGerm cell tumor patientsCarboplatin-based regimensCisplatin-based regimensParametric cure modelsLeukemia groupTumor patientsStandard riskChildren's CancerRegimensCancerRiskTrialsGroupCure modelPatientsCarboplatinInternational ConsortiumCisplatin
2012
Children's Oncology Group's 2013 blueprint for research: Rare tumors
Rodriguez‐Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee O. Children's Oncology Group's 2013 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2012, 60: 1016-1021. PMID: 23255219, PMCID: PMC4304764, DOI: 10.1002/pbc.24428.Peer-Reviewed Original ResearchConceptsGerm cell tumorsCell tumorsRare cancersChildren's Oncology Group's 2013 blueprintInternational phase 3 clinical trialsPhase 3 clinical trialsEvidence-based definitionIntraocular retinoblastomaAdvanced carcinomaRisk stratificationInfrequent malignancyRare tumorClinical trialsClinical studiesLiver tumorsTumorsBiologic studiesChildrenCancerRetinoblastomaCarcinomaMalignancyHepatoblastomaYearsTrialsManagement of Thyroid Carcinoma in Children and Young Adults
Rapkin L, Pashankar FD. Management of Thyroid Carcinoma in Children and Young Adults. Journal Of Pediatric Hematology/Oncology 2012, 34: s39-s46. PMID: 22525405, DOI: 10.1097/mph.0b013e31824e37a6.Peer-Reviewed Original ResearchConceptsMedullary thyroid cancerThyroid cancerRadioactive iodineCancers of childhoodSuppression of thyroidPediatric carcinomasAdjuvant benefitNew medicationsSuspicious lesionsThyroid carcinomaBeneficial treatmentCancerAdolescent treatmentPatientsYoung adultsAdult dataWDTCSurgeryCarcinomaTreatmentChildhoodLow thresholdLarge groupMedicationsVandetanibDevelopment of a Therapeutic Approach to Rare Cancers in Children
Pashankar FD, Rodriguez-Galindo C, Pappo A. Development of a Therapeutic Approach to Rare Cancers in Children. Journal Of Pediatric Hematology/Oncology 2012, 34: s37-s38. PMID: 22525404, DOI: 10.1097/mph.0b013e31824e378e.Peer-Reviewed Original Research
2011
Acute Constipation in Children Receiving Chemotherapy for Cancer
Pashankar FD, Season JH, McNamara J, Pashankar DS. Acute Constipation in Children Receiving Chemotherapy for Cancer. Journal Of Pediatric Hematology/Oncology 2011, 33: e300-e303. PMID: 21941132, DOI: 10.1097/mph.0b013e31821a0795.Peer-Reviewed Original ResearchConceptsDevelopment of constipationAcute constipationRisk factorsBowel movement patternDiagnosis of constipationSeverity of constipationUse of vincristineSignificant risk factorsAggressive managementGroup of childrenPediatric GastroenterologyConstipationChemotherapyNutrition criteriaMore weeksCancerParental perceptionsNorth American SocietySignificant problemAmerican SocietyChildrenVincristineOpiatesLifestyleCombined use
2009
T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the Problem
Season H, Pashankar F, Beardsley D, McNamara J, Pashankar D. T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the Problem. Gastroenterology 2009, 136: a-511. DOI: 10.1016/s0016-5085(09)62354-4.Peer-Reviewed Original Research